Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 186

Similar articles for PubMed (Select 11593072)

1.

Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics.

Potkin SG, Fleming K, Jin Y, Gulasekaram B.

J Clin Psychopharmacol. 2001 Oct;21(5):479-83.

PMID:
11593072
2.

Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.

Rémillard S, Pourcher E, Cohen H.

J Int Neuropsychol Soc. 2008 Jan;14(1):110-8.

PMID:
18078537
3.

A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.

Akdede BB, Anil Yağcioğlu AE, Alptekin K, Turgut TI, Tümüklü M, Yazici MK, Jayathilake K, Tunca Z, Göğüş A, Meltzer HY.

J Clin Psychiatry. 2006 Dec;67(12):1912-9.

PMID:
17194269
4.

Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.

Krakowski MI, Czobor P, Nolan KA.

J Clin Psychopharmacol. 2008 Oct;28(5):485-93. doi: 10.1097/JCP.0b013e3181855cd6.

PMID:
18794642
5.

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.

Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M, Sheitman B, Lindenmayer JP, Citrome L, McEvoy J, Kunz M, Chakos M, Cooper TB, Horowitz TL, Lieberman JA.

Am J Psychiatry. 2002 Jun;159(6):1018-28.

PMID:
12042192
6.

[Cognition, schizophrenia and the effect of antipsychotics].

Stip E.

Encephale. 2006 May-Jun;32(3 Pt 1):341-50. Review. French.

PMID:
16840928
7.

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.

Keefe RS, Seidman LJ, Christensen BK, Hamer RM, Sharma T, Sitskoorn MM, Lewine RR, Yurgelun-Todd DA, Gur RC, Tohen M, Tollefson GD, Sanger TM, Lieberman JA.

Am J Psychiatry. 2004 Jun;161(6):985-95.

PMID:
15169686
8.

Cholesterol and cognition in schizophrenia: a double-blind study of patients randomized to clozapine, olanzapine and haloperidol.

Krakowski M, Czobor P.

Schizophr Res. 2011 Aug;130(1-3):27-33. doi: 10.1016/j.schres.2011.04.005. Epub 2011 May 6.

PMID:
21549568
9.

Association of symptomatology and cognitive deficits to functional capacity in schizophrenia.

Perlick DA, Rosenheck RA, Kaczynski R, Bingham S, Collins J.

Schizophr Res. 2008 Feb;99(1-3):192-9. Epub 2007 Sep 12.

PMID:
17851042
10.

Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.

Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M.

J Clin Psychiatry. 2004 Apr;65(4):551-6.

PMID:
15119920
11.

The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia.

Smith RC, Infante M, Singh A, Khandat A.

Int J Neuropsychopharmacol. 2001 Sep;4(3):239-50.

PMID:
11669086
12.

A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia.

Chengappa KN, Goldstein JM, Greenwood M, John V, Levine J.

Clin Ther. 2003 Feb;25(2):530-41.

PMID:
12749512
13.
14.

Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.

Houthoofd SA, Morrens M, Sabbe BG.

Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Review.

PMID:
18840365
15.

Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.

Harvey PD, Rabinowitz J, Eerdekens M, Davidson M.

Am J Psychiatry. 2005 Oct;162(10):1888-95.

PMID:
16199835
16.

Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.

Buchanan RW, Breier A, Kirkpatrick B, Ball P, Carpenter WT Jr.

Am J Psychiatry. 1998 Jun;155(6):751-60.

PMID:
9619146
17.

The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes.

Arango C, Breier A, McMahon R, Carpenter WT Jr, Buchanan RW.

Am J Psychiatry. 2003 Aug;160(8):1421-7.

PMID:
12900303
18.

Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia.

Umbricht DS, Wirshing WC, Wirshing DA, McMeniman M, Schooler NR, Marder SR, Kane JM.

J Clin Psychiatry. 2002 May;63(5):420-4.

PMID:
12019667
19.

The effects of clozapine on cognitive functioning in treatment-resistant schizophrenic patients.

Fujii DE, Ahmed I, Jokumsen M, Compton JM.

J Neuropsychiatry Clin Neurosci. 1997 Spring;9(2):240-5.

PMID:
9144103
20.

The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study.

Rémillard S, Pourcher E, Cohen H.

Schizophr Res. 2005 Dec 1;80(1):99-106. Epub 2005 Sep 12.

PMID:
16162401
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk